MCVAX Fees and Costs — Transamerica Mid Cap Value Opportunities, Class A
Data updated: 2026-09-28
The net expense ratio is 1.18%: a 0.69% management fee, a 0.25% 12b-1 fee plus 0.24% other expenses. This share class carries a maximum front-end sales load of 5.50%. In fiscal 2025 the fund paid $609K in broker commissions, 0.0580% of average net assets, and portfolio turnover was 59%.
MCVAX Fees and Expenses
Annual operating expenses and sales charges of MCVAX. Prospectus, as of October 31, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.69% |
| 12b-1 fee | 0.25% |
| Other expenses | 0.24% |
| Gross expense ratio | 1.18% |
| Fee waiver | — |
| Net expense ratio | 1.18% |
| Sales charges | |
|---|---|
| Max front load | 5.50% |
| Max deferred load | 0.00% |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | Yes |
MCVAX Costs Over Time
On $10,000 invested in MCVAX, assuming 5% a year before costs, total costs come to $1,430 over 5 years, cutting the return by 2.47% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Sales charges | $550 | $550 | $550 |
| Fund expenses (net expense ratio 1.18%) | $117 | $364 | $630 |
| Trading costs (broker commissions) | $6 | $18 | $31 |
| Lost growth on money paid in costs | $28 | $106 | $219 |
| Total costs | $700 | $1,038 | $1,430 |
| Value after costs | $9,800 | $10,538 | $11,333 |
| Impact on return, per year | 7.00% | 3.24% | 2.47% |
MCVAX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending October 31, 2025.
- Explicit cost rate (commissions ÷ average net assets): 0.0580%
- Total broker commissions: $609K
- Bought from dealers (principal trades, not a cost): $13.5B
- Portfolio turnover (prospectus): 59%
- Securities on loan, average value: $14.5M
- Net income from securities lending: $33K (0.003% of average net assets)
MCVAX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| Capital Institutional Services, Inc. | $88K | 25.10% |
| Liquidnet, Inc. | $46K | 13.13% |
| State Street Global Markets, LLC | $41K | 11.60% |
| Sanford C. Bernstein & Co., LLC | $35K | 10.02% |
| RBC Capital Markets, LLC | $32K | 9.23% |
| Kezar Trading, LLC | $29K | 8.22% |
| Evercore Group L.L.C. | $26K | 7.48% |
| Stifel, Nicolaus & Company, Incorporated | $20K | 5.72% |
| UBS Securities LLC | $17K | 4.92% |
| Robert W. Baird & Co. Incorporated | $16K | 4.58% |
MCVAX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| State Street Bank and Trust Company | $13.5B | 100.00% |
Transamerica Mid Cap Value Opportunities Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| IAAEX | Class I2 | 0.75% | none |
| MVTRX | Class R6 | 0.75% | none |
| TOTTX | Class I3 | 0.75% | none |
| MVTIX | Class I | 0.85% | none |
| TOTFX | Class R4 | 0.90% | none |
| MCVAX | Class A | 1.18% | 5.50% |
| TOTRX | Class R | 1.24% | none |
| MCVCX | Class C | 1.87% | none |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.